Pre-surgical mapping of primary motor cortex by functional MRI at 3 T: Effects of intravenous administration of Gd-DTPA

European Radiology

Volumn 14, Issue 1, 2004, Pages 112-114

  Naganawa, Shinji ^a   Nihashi, Takashi ^a   Fukatsu, Hiroshi ^a   Ishigaki, Takeo ^a   Aoki, Ikuo ^b  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOSHIBA MEDICAL SYSTEMS CORPORATION   (Japan)

Author keywords

Brain motor cortex; Functional MRI; Gd DTPA

Indexed keywords

GADOLINIUM PENTETATE;

ARTICLE; BLOOD OXYGENATION; BRAIN MAPPING; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN EXPERIMENT; MOTOR CORTEX; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RADIODIAGNOSTIC EQUIPMENT AND SUPPLIES; SIGNAL PROCESSING;

ADULT; BRAIN MAPPING; FEMALE; GADOLINIUM DTPA; HUMANS; INFUSIONS, INTRAVENOUS; MAGNETIC RESONANCE IMAGING; MALE; MOTOR CORTEX; PREOPERATIVE CARE; PROBABILITY; REFERENCE VALUES; SAMPLING STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 0842345485     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-003-2147-6     Document Type: Article

References (22)

1. Purdon PL, Solo V, Weisskoff RM, Brown EN (2001) Locally regularized spatiotemporal modeling and model comparison for functional MRI. Neuroimage 14:912-923
2. Allard M, Caille JM, Bonnemain B, Meyer D, Simonnet G (1986) Action of gadolinium complexes on different enzyme systems. Acta Radiol (Suppl) 369:572-574
3. Staks T, Schuhmann-Giampieri G, Frenzel T, Weinmann HJ, Lange L, Platzek J (1994) Pharmacokinetics, dose proportionality, and tolerability of gadobutrol after single intravenous injection in healthy volunteers. Invest Radiol 29:709-715
4. Kuperman VY, Karczmar GS, Blomley MJ, Lewis MZ, Lubich LM, Lipton MJ (1996) Differentiating between T1 and T2* changes caused by gadopentetate dimeglumine in the kidney by using a double-echo dynamic MR imaging sequence. J Magn Reson Imaging 6:764-768
5. Harpur ES, Worah D, Hats PA, Holtz E, Furuhama K, Nomura H (1993) Pre-clinical safety assessment and pharmacokinetics of gadodiamide injection, a new magnetic resonance imaging contrast agent. Invest Radiol 28 (Suppl 1): S28-S43
6. Niendorf HP, Alhassan A, Geens VR, Clauss W (1994) Safety review of gadopentetate dimeglumine: extended clinical experience after more than five million applications. Invest Radiol 29 (Suppl 2): S179-S182
7. Weinmann HJ, Press WR, Gries H (1990) Tolerance of extracellular contrast agents for magnetic resonance imaging. Invest Radiol 25 (Suppl 1):S49-S50
8. Lin AP, Ross BD (2001) Short-echotime proton MR spectroscopy in the presence of gadolinium. J Comput Assist Tomogr 25:705-712
9. Sijens PE, van den Bent MJ, Nowak PJ, van Dijk P, Oudkerk M (1997) 1H chemical shift imaging reveals loss of brain tumor choline signal after administration of Gd-contrast. Magn Reson Med 37:222-225
10. Sijens PE, Oudkerk M, van Dijk P, Levendag PC, Vecht CJ (1998) 1H MR spectroscopy monitoring of changes in choline peak area and line shape after Gd-contrast administration. Magn Reson Imaging 16:1273-1280
11. Aubert A, Costalat R (2002) A model of the coupling between brain electrical activity, metabolism, and hemodynamics: application to the interpretation of functional neuroimaging. Neuroimage 17:1162-1181
12. Mildner T, Norris DG, Schwarzbauer C, Wiggins CJ (2001) A qualitative test of the balloon model for BOLD-based MR signal changes at 3 T. Magn Reson Med 46:891-899
13. Laurienti P, Field A, Burdette J, Maldjian J, Yen Y, Moody D (2002) Dietary caffeine consumption modulates fMRI measures. Neuroimage 17:751
14. Mulderink TA, Gitelman DR, Mesulam MM, Parrish TB (2002) On the use of caffeine as a contrast booster for BOLD fMRI studies. Neuroimage 15:37-44
15. Li TQ, Mathews VP (2002) How can we make BOLD contrast bolder? Am J Neuroradiol 23:507-508
16. Levin JM, Ross MH, Mendelson JH, Kaufman MJ, Lange N, Maas LC et al. (1998) Reduction in BOLD fMRI response to primary visual stimulation following alcohol ingestion. Psychiatry Res 82:135-146
17. Seifritz E, Bilecen D, Hanggi D, Haselhorst R, Radu EW, Wetzel S et al. (2000) Effect of ethanol on BOLD response to acoustic stimulation: implications for neuropharmacological fMRI. Psychiatry Res 99:1-13
18. Naganawa S, Norris DG, Zysset S, Mildner T (2002) Regional differences of fMR signal changes induced by hyperventilation: comparison between SE-EPI and GE-EPI at 3 T. J Magn Reson Imaging 15:23-30
19. Kastrup A, Li TQ, Takahashi A, Glover GH, Moseley ME (1998) Functional magnetic resonance imaging of regional cerebral blood oxygenation changes during breath holding. Stroke 29:2641-2645
20. Schreiber A, Hubbe U, Ziyeh S, Hennig J (2000) The influence of gliomas and nonglial space-occupying lesions on blood-oxygen-level-dependent contrast enhancement. Am J Neuroradiol 21:1055-1063
21. Bilecen D, Radu EW, Schulte AC, Hennig J, Scheffler K, Seifritz E (2002) fMRI of the auditory cortex in patients with unilateral carotid artery steno-occlusive disease. J Magn Reson Imaging 15:621-627
22. Lythgoe DJ, Williams SC, Cullinane M, Markus HS (1999) Mapping of cerebrovascular reactivity using BOLD magnetic resonance imaging. Magn Reson Imaging 17:495-502